EFSA: Appethyl® as part of a meal prolongs satiety/reduces cravings after that meal: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Following an application from Lars Jansson, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to «Appethyl® as part of a meal prolongs satiety/reduces cravings after that meal». Appethyl® is an aqueous extract from spinach leaves standardised by the manufacturing process and its lipase/colipase inhibition capacity in vitro.
The Panel had evaluated the characterisation of Appethyl® in a previous opinion and as there were no changes made to the characterisation of Appethyl® in the current application, the Panel considers the food/constituent sufficiently characterised. The Panel notes that the claimed effect refers to changes in appetite ratings, which are not considered a beneficial physiological effect per se, and that no beneficial physiological effect resulting from changes in appetite ratings has been identified by the applicant. The Panel concludes that a cause-and-effect relationship between the consumption of Appethyl® and a beneficial physiological effect cannot be established in the context of this application.
EFSA - European Food Safety Authority | EFSA-Journal Volume 24, Issue 10, October 2026